Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 4
2006 12
2007 82
2008 206
2009 237
2010 248
2011 258
2012 283
2013 303
2014 313
2015 308
2016 257
2017 258
2018 245
2019 114
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

2,656 results
Results by year
Filters applied: . Clear all
Page 1
[Acute coronary syndrome].
Thiele H. Herz 2014. PMID 25062718 German.
Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin.
Garg P, et al. Intern Emerg Med 2017 - Review. PMID 28188579 Free PMC article.
The role of cardiac troponins as diagnostic biomarkers of myocardial injury in the context of acute coronary syndrome (ACS) is well established. ...We aim to provide insights into using hs-cTn as a quantitative marker of cardiomyocyte injury to help in the differential diagnosis of coronary versus non-coronary cardiac diseases. ...
The role of cardiac troponins as diagnostic biomarkers of myocardial injury in the context of acute coronary syndrome (ACS) is …
Acute Coronary Syndrome: Diagnostic Evaluation.
Barstow C, et al. Am Fam Physician 2017. PMID 28145667 Free article.
Myocardial infarction (MI), a subset of acute coronary syndrome, is damage to the cardiac muscle as evidenced by elevated cardiac troponin levels in the setting of acute ischemia. ...In some patients with negative electrocardiography findings and normal cardiac biomarkers, additional testing may further reduce the likelihood of coronary artery disease. ...
Myocardial infarction (MI), a subset of acute coronary syndrome, is damage to the cardiac muscle as evidenced by elevated card …
The Role of Hematological Indices in Patients with Acute Coronary Syndrome.
Budzianowski J, et al. Dis Markers 2017 - Review. PMID 29109595 Free PMC article.
An increased systemic and local inflammation plays a key role in the pathophysiology of acute coronary syndrome (ACS). This review will discuss the role of hematological indices: white blood cells (WBC), neutrophil to lymphocyte ratio (NLR), red cell distribution width (RDW), and platelet indices, that is, platelet to lymphocyte ratio (PLR), mean platelet volume (MPV), and platelet distribution width (PDW) in the case of ACS. ...Furthermore, many studies have pointed at their effective prognostic value in all-cause mortality, major cardiovascular events, stent thrombosis, arrhythmias, and myocardial perfusion disorders in terms of acute myocardial infarction and unstable angina. ...
An increased systemic and local inflammation plays a key role in the pathophysiology of acute coronary syndrome (ACS). This re …
A consensus statement on lipid management after acute coronary syndrome.
Schiele F, et al. Eur Heart J Acute Cardiovasc Care 2018 - Review. PMID 27856518
In patients admitted for acute coronary syndrome (ACS), the guidelines of the European Society of Cardiology give a Class I, Level A recommendation for the prescription of high-intensity statins to be initiated as early as possible, regardless of the low-density lipoprotein cholesterol (LDL-C) level. ...This paper outlines the scientific rationale for the use of statins at the acute phase of ACS, the utility of ezetimibe, the measurement of LDL-C during the course of ACS, the opportunities for detecting familial hypercholesterolaemia and the results of the consensus for the management of lipid-lowering therapy, illustrated in two decision-making algorithms....
In patients admitted for acute coronary syndrome (ACS), the guidelines of the European Society of Cardiology give a Class I, L …
Genome-Wide Analysis of DNA Methylation and Acute Coronary Syndrome.
Li J, et al. Circ Res 2017. PMID 28348007
RATIONALE: Acute coronary syndrome (ACS) is a leading cause of death worldwide. Immune functions play a vital role in ACS development; however, whether epigenetic modulation contributes to the regulation of blood immune cells in this disease has not been investigated. ...The replicated loci suggested a role in ACS-relevant functions including chemotaxis, coronary thrombosis, and T-cell-mediated cytotoxicity. ...
RATIONALE: Acute coronary syndrome (ACS) is a leading cause of death worldwide. Immune functions play a vital role in ACS deve …
[Diagnostic and prognostic biomarkers in acute coronary syndrome].
Kuběna P, et al. Vnitr Lek 2018 - Review. PMID 29334742 Czech.
The aim of this article is to provide a comprehensive overview of the most important and most examined biomarkers in acute coronary syndrome. ...More prospective randomized studies are needed for the further use of these other biomarkers in clinical practice.Key words: acute coronary syndrome - biomarkers....
The aim of this article is to provide a comprehensive overview of the most important and most examined biomarkers in acute coronar
Microparticles in acute coronary syndrome.
Mavroudis CA, et al. Thromb Res 2017. PMID 28624718
BACKGROUND: Emerging evidence supports the role of cell-derived microparticles (MPs) in the pathophysiology of acute coronary syndrome (ACS). OBJECTIVES: To explore the relationship between coronary and systemic MP levels, investigate the correlation between MPs, inflammatory markers and Troponin T in patients with ACS. ...
BACKGROUND: Emerging evidence supports the role of cell-derived microparticles (MPs) in the pathophysiology of acute coronary
Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes.
Sasso FC, et al. J Diabetes Res 2018 - Review. PMID 30402502 Free PMC article.
Both incidence and mortality of acute coronary syndrome (ACS) among diabetic patients are much higher than those among nondiabetics. ...Moreover, high FFA concentrations may be toxic in acute ischemic myocardium due to several mechanisms, thus leading to endothelial dysfunction. ...
Both incidence and mortality of acute coronary syndrome (ACS) among diabetic patients are much higher than those among nondiab …
Diagnostic and prognostic value of H-FABP in acute coronary syndrome: Still evidence to bring.
Bivona G, et al. Clin Biochem 2018 - Review. PMID 29698621
The assessment of chest pain patients presenting to the emergency area (EA) is still a clinical challenge, as the majority of patients are not diagnosed with acute coronary syndrome (ACS). ...This article reviews the studies evaluating H-FABP performance in diagnosing acute myocardial infarction (AMI) and stratifying chest pain patients by risk. ...
The assessment of chest pain patients presenting to the emergency area (EA) is still a clinical challenge, as the majority of patients are n …
2,656 results
Jump to page
Feedback